Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | 3,337.42%53.64M | 267.92%67.5M | 85.04%-1.66M | -89.06%18.35M | -109.79%-11.08M | -35.65%167.71M | -15.05%113.14M | 1,426.87%260.61M | 210.27%133.19M | -75.87%17.07M |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | -20.67%-21.46M | -0.75%-35.56M | -131.15%-17.79M | -76.04%-35.3M | 45.04%-7.69M | 5.21%-20.05M | -70.72%-14M | -146.72%-21.15M | -112.82%-8.2M | 8.85%-8.57M |
| Investment loss (gain) | ---- | -102.67%-1.34M | ---- | 75.86%50.33M | ---- | --28.62M | ---- | ---- | ---- | ---- |
| Impairment and provisions: | 62.83%3.14M | 155.34%1.14M | 2,424.10%1.93M | -489.18%-2.05M | -103.84%-83K | 126.39%527K | 242.80%2.16M | 29.58%-2M | -120.19%-1.51M | -201.70%-2.84M |
| -Impairment of property, plant and equipment (reversal) | ---- | ---- | ---- | --267K | ---- | ---- | ---- | ---- | ---- | ---- |
| -Impairmen of inventory (reversal) | 106.49%3.85M | -16.42%-2.09M | 1,311.36%1.86M | -440.49%-1.79M | -93.43%132K | 129.73%526K | 235.99%2.01M | 34.99%-1.77M | -119.24%-1.48M | -263.92%-2.72M |
| -Impairment of trade receivables (reversal) | -1,020.51%-718K | 145.75%199K | 137.50%78K | -43,600.00%-435K | -236.84%-208K | 100.91%1K | 141.27%152K | 4.35%-110K | 134.43%63K | 95.58%-115K |
| -Impairment of goodwill | ---- | --3.01M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Other impairments and provisions | 200.00%12K | 110.87%10K | -71.43%-12K | ---92K | ---7K | ---- | ---- | ---118K | ---99K | ---- |
| Revaluation surplus: | ---- | ---- | -97.56%230K | ---- | 921.90%9.42M | ---- | ---1.15M | ---- | ---- | ---- |
| -Other fair value changes | ---- | ---- | -97.56%230K | ---- | 921.90%9.42M | ---- | ---1.15M | ---- | ---- | ---- |
| Asset sale loss (gain): | -94.92%52K | -63.42%1.19M | --1.02M | 3,803.41%3.26M | ---- | 99.15%-88K | ---- | -1,167.60%-10.31M | ---10.8M | --966K |
| -Loss (gain) from sale of subsidiary company | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---10.82M | ---10.82M | ---- |
| -Loss (gain) on sale of property, machinery and equipment | -94.92%52K | -63.42%1.19M | --1.02M | 3,803.41%3.26M | ---- | -117.29%-88K | ---- | -47.31%509K | --23K | --966K |
| Depreciation and amortization: | 23.27%56.81M | 15.30%97.82M | -13.10%46.08M | 5.04%84.84M | 52.78%53.03M | -46.89%80.77M | -67.54%34.71M | -17.89%152.07M | 34.28%106.93M | 39.22%185.21M |
| -Depreciation | ---- | 23.26%92.03M | ---- | 16.93%74.66M | ---- | -52.96%63.85M | ---- | -19.78%135.74M | ---- | 39.97%169.22M |
| -Amortization of intangible assets | 5.15%1.39M | -5.15%4.33M | 5.43%1.32M | 61.40%4.57M | 26.98%1.25M | 34.27%2.83M | -13.36%986K | 0.81%2.11M | 21.58%1.14M | 25.15%2.09M |
| Financial expense | 15,976.47%8.2M | 1,651.46%11.4M | -91.39%51K | -60.45%651K | -35.09%592K | -37.34%1.65M | -40.66%912K | -64.50%2.63M | -73.70%1.54M | -77.98%7.4M |
| Exchange Loss (gain) | 825.55%1.27M | 100.53%119K | 103.17%137K | -33.29%-22.65M | -1,014.62%-4.32M | -1,308.46%-16.99M | 24.54%472K | -73.69%1.41M | 49.80%379K | 5.07%5.34M |
| Special items | ---- | --1.55M | ---- | ---- | ---- | 90.00%-72K | ---- | -718.18%-720K | ---14K | 73.25%-88K |
| Operating profit before the change of operating capital | 238.73%101.65M | 47.61%143.81M | -24.73%30.01M | -59.75%97.43M | -70.74%39.87M | -36.72%242.07M | -38.49%136.25M | 87.06%382.53M | 805.22%221.51M | -11.78%204.5M |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | -2,082.03%-145.74M | -93.44%-123.26M | -168.87%-6.68M | -123.57%-63.72M | -95.33%9.7M | 40.39%270.4M | -28.83%207.67M | 151.18%192.61M | 208.35%291.77M | -209.56%-376.34M |
| Accounts receivable (increase)decrease | -270.84%-510.57M | -373.90%-517.35M | 17.58%-137.68M | 98.45%188.88M | -180.52%-167.04M | 72.58%95.18M | 76.90%-59.55M | -93.51%55.15M | -125.63%-257.77M | 197.26%849.53M |
| Accounts payable increase (decrease) | 18.23%410.03M | 3,342.71%1.02B | 1,427.05%346.81M | 92.98%-31.54M | 89.53%-26.13M | -3,406.62%-449.54M | -304.10%-249.72M | -97.99%13.6M | 136.15%122.35M | 156.81%678M |
| prepayments (increase)decrease | -96.45%1.5M | 156.58%43.45M | 13,922.30%42.16M | -716.33%-76.79M | 98.37%-305K | 844.27%12.46M | -162.36%-18.69M | -116.05%-1.67M | 10.93%29.97M | -71.19%10.43M |
| Derivative financial instruments (increase) decrease | ---- | -122.05%-2.55M | 102.42%229K | 213.82%11.56M | 15.07%-9.48M | -982.62%-10.16M | -1,154.44%-11.16M | 799.22%1.15M | 440.19%1.06M | 196.24%128K |
| Special items for working capital changes | -125.66%-1.81M | -23.39%-3.41M | -7.43%7.05M | -81.14%-2.77M | 40.23%7.62M | 59.09%-1.53M | 384.65%5.43M | -127.95%-3.73M | -118.77%-1.91M | 339.57%13.35M |
| Cash from business operations | -151.42%-144.95M | 357.96%563.54M | 293.39%281.9M | -22.55%123.05M | -1,522.68%-145.77M | -75.16%158.88M | -97.48%10.25M | -53.64%639.63M | -64.84%406.99M | 570.28%1.38B |
| Hong Kong profits tax paid | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 93.05%-128K | ---- |
| China income tax paid | -1.67%-9.34M | -16.35%-20.14M | -476.47%-9.19M | 41.12%-17.31M | 79.31%-1.59M | 25.36%-29.39M | 46.01%-7.7M | -89.96%-39.38M | 1.08%-14.27M | 38.95%-20.73M |
| Net cash from operations | -156.58%-154.29M | 413.86%543.4M | 285.06%272.71M | -18.34%105.75M | -5,897.09%-147.36M | -78.43%129.49M | -99.35%2.54M | -55.83%600.26M | -65.60%392.59M | 515.16%1.36B |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | 20.67%21.46M | 0.75%35.56M | 131.15%17.79M | 76.04%35.3M | -45.04%7.69M | -5.21%20.05M | 70.72%14M | 146.72%21.15M | 112.82%8.2M | -8.85%8.57M |
| Loan receivable (increase) decrease | ---- | ---- | ---- | 200.00%693.25M | --693.25M | ---693.25M | ---- | ---- | ---- | ---- |
| Decrease in deposits (increase) | 226.77%291.22M | 58.17%-354.08M | ---229.72M | ---846.4M | ---- | ---- | ---- | ---19M | ---40M | ---- |
| Sale of fixed assets | -92.01%23K | -77.87%789K | 111.93%288K | 322.51%3.57M | -3,235.06%-2.41M | -45.12%844K | -95.89%77K | 8.01%1.54M | 395.24%1.87M | --1.42M |
| Purchase of fixed assets | -99.36%-108.67M | -8.86%-164.55M | 38.41%-54.51M | 10.93%-151.15M | -11.07%-88.5M | 28.96%-169.7M | 38.74%-79.68M | -14.80%-238.89M | 23.98%-130.07M | 47.60%-208.1M |
| Purchase of intangible assets | ---- | -133.00%-1.87M | ---- | 34.07%-803K | ---- | -49.26%-1.22M | ---- | 69.51%-816K | -407.69%-396K | 91.65%-2.68M |
| Sale of subsidiaries | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --282.81M | --82.61M | ---- |
| Acquisition of subsidiaries | ---- | ---- | ---- | ---- | ---- | ---50.13M | ---- | ---- | ---- | ---- |
| Recovery of cash from investments | ---- | 102.67%1.34M | ---- | -923.72%-50.33M | ---- | --6.11M | ---- | ---- | ---- | ---- |
| Net cash from investment operations | 176.66%204.03M | -52.51%-482.81M | -143.63%-266.16M | 64.32%-316.58M | 1,029.86%610.02M | -1,996.29%-887.29M | 15.66%-65.6M | 123.31%46.79M | 53.41%-77.79M | 52.17%-200.78M |
| Net cash before financing | 658.71%49.74M | 128.74%60.6M | -98.58%6.56M | 72.18%-210.83M | 833.66%462.66M | -217.12%-757.8M | -120.03%-63.06M | -44.13%647.05M | -67.69%314.8M | 255.02%1.16B |
| Cash flow from financing activities | ||||||||||
| New borrowing | ---- | ---- | ---- | -94.76%3.16M | ---- | -17.62%60.32M | -44.63%67M | -62.31%73.22M | -51.20%121M | -82.51%194.29M |
| Refund | ---- | 94.93%-3.16M | 94.69%-3.16M | 18.24%-62.32M | -9.78%-59.51M | -74.06%-76.22M | -10,741.40%-54.21M | 95.66%-43.79M | 99.95%-500K | -117.95%-1.01B |
| Issuing shares | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --117K | ---- | ---- |
| Interest paid - financing | ---8.18M | -1,645.71%-11.38M | ---- | 60.53%-652K | -39.08%-1.03M | 89.67%-1.65M | 95.01%-737K | -111.98%-15.99M | -165.84%-14.76M | 76.95%-7.55M |
| Issuance expenses and redemption of securities expenses | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---8.42M | ---8.42M | ---- |
| Net cash from financing operations | -158.75%-8.18M | 76.92%-14.91M | 94.78%-3.16M | -93.39%-64.58M | -1,564.27%-60.53M | -280.74%-33.39M | -95.42%4.13M | 98.95%-8.77M | 111.72%90.33M | -246.64%-835.63M |
| Effect of rate | -98.38%157K | -134.26%-6.72M | 0.13%9.71M | 17.27%19.61M | -54.53%9.7M | 1,171.17%16.72M | 5,804.01%21.33M | 77.03%-1.56M | -1,396.00%-374K | -890.35%-6.8M |
| Net Cash | 1,124.21%41.56M | 116.59%45.69M | -99.16%3.4M | 65.19%-275.4M | 782.41%402.13M | -223.96%-791.19M | -114.55%-58.93M | 97.93%638.28M | 99.27%405.13M | 281.94%322.47M |
| Begining period cash | 168.14%62.15M | -91.69%23.18M | -91.69%23.18M | -73.52%278.97M | -73.52%278.97M | 152.79%1.05B | 152.79%1.05B | 312.38%416.73M | 312.38%416.73M | -63.58%101.05M |
| Cash at the end | 186.25%103.87M | 168.14%62.15M | -94.75%36.29M | -91.69%23.18M | -32.00%690.8M | -73.52%278.97M | 23.66%1.02B | 152.79%1.05B | 169.93%821.49M | 312.38%416.73M |
| Cash balance analysis | ||||||||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.